New Market Report: Market and Product Forecasts: Top 20 Oncology Therapy Brands 2011-21 - Avastin Fails to Top Any Individual Market in 2011
The high level of commercial success experienced by the key companies in the cancer therapy market makes the market extremely attractive to drug developers. Treatment of cancer has shifted toward a more focused attack on the disease with targeted therapies. However, austerity packages imposed could see slower commercial growth and larger generic erosion of key brands.
View full press release